Fatty Liver Disease Clinical Trials

34 clinical trials for Fatty Liver Disease across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• NAC- NAFLD And Cushing — RECRUITING · NA
• The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults — RECRUITING · NA
• Digoxin In NASH (CODIN) — RECRUITING · PHASE2
• Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study) — RECRUITING · NA
• A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat — RECRUITING · PHASE1
• Liver Disease and Other Systemic Diseases — RECRUITING
• Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly — RECRUITING · NA
• LivQ-box® Parameters in the Diagnosis of Liver Inflammation — RECRUITING
• The Role of Sugars in Fat Accumulation in the Liver — RECRUITING · NA
• Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity — RECRUITING
• Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis — RECRUITING · NA
• Prevalence of Advanced Fibrosis in Patients Living With HIV — RECRUITING
• Assessment of Fatty Liver With Thermo-acoustic Device — WITHDRAWN
• Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load — COMPLETED · PHASE4
• A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 — COMPLETED · PHASE1
• Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease — NOT_YET_RECRUITING
• Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism — COMPLETED · NA
• Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV — NOT_YET_RECRUITING
• Impact of Fatty Liver on Hepatitis B Therapy — ACTIVE_NOT_RECRUITING
• Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue Assessment — COMPLETED · NA
• A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease — COMPLETED
• Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis — OTHER · PHASE1
• Impact of Time-restricted Feeding in NAFLD — OTHER · NA
• Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) — OTHER · PHASE2
• Effect of Thyroid Disorders in Liver Diseases — OTHER
• Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting — OTHER · NA
• Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients — COMPLETED · NA
• SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity — COMPLETED · NA
• Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis — TERMINATED · PHASE1
• Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) — OTHER
• Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver — OTHER · NA
• Fatty Liver Among Employees at Banha University — COMPLETED
• Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS) — OTHER
• Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease — COMPLETED · PHASE1

Refine this search